Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

about

Analysis, Nutrition, and Health Benefits of Tryptophan

P2860

Q57069256-94E7A703-4EBA-45AE-8B3E-1ECE13B4A5B2

P2860

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

Item

http://www.wikidata.org/entity/Q48226851

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

@en

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

@nl

type

Item

label

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

@en

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

@nl

prefLabel

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

@en

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

@nl

P1476

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

@en

P2093

Chia-Ni Lin

http://www.w3.org/2001/XMLSchema#string

Chien-An Chou

http://www.w3.org/2001/XMLSchema#string

Daniel Tsun-Yee Chiu

http://www.w3.org/2001/XMLSchema#string

I-Wen Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and molecular cell biology of diabetic complications

MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers.

Metabolite profiling identifies markers of uremia.

Globalization of diabetes: the role of diet, lifestyle, and genes.

Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

The gut microbiome, kidney disease, and targeted interventions.

Diabetic nephropathy in type 2 diabetes prevention and patient management.

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.

P304

366-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDI.12707

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Szu-Tah Chen

P577

2017-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28646618

http://www.w3.org/2001/XMLSchema#string

P932

5835459

http://www.w3.org/2001/XMLSchema#string

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

about

P2860

P2860

Tryptophan as a surrogate prognostic marker for diabetic nephropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932